Anthracycline Chemotherapy Triggers Chromatin Shifts Enabling ALDH1-Driven Resistance in Leukemia
Anthracycline-induced chromatin alterations activate ALDH1 enhancers via STAT3 and c-JUN, driving therapy resistance in acute myeloid leukemia cells.
Anthracycline-induced chromatin alterations activate ALDH1 enhancers via STAT3 and c-JUN, driving therapy resistance in acute myeloid leukemia cells.
Alpha-mangostin triggered apoptosis and showed concentration-dependent synergy with daunorubicin in acute leukemia cell models, while displaying a narrow in vitro ...
Researchers have developed an electrochemical sensor that directly measures unencapsulated daunorubicin in intact liposomal formulations, eliminating the need for time-consuming ...
New research shows that the surface protein CD7 actively drives chemotherapy resistance in acute myeloid leukemia by amplifying NF-κB signaling, ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine